Takeda Divests to Hikma and Esteve in Strategic Move
Deal News | Feb 12, 2025 | Iberian Lawyer
White & Case has played a pivotal role in advising Takeda Pharmaceutical Company Limited in two significant divestments. First, Takeda has agreed to divest a portfolio of pharmaceutical products to Hikma Pharmaceuticals for specific territories in the Middle East and North Africa. This strategic move allows Takeda to streamline its operations and focus more intensely on its core areas of interest, including gastroenterology and oncology. Second, Takeda is divesting its oncology product, MEPACT, to Esteve Pharmaceutical. Both divestments are subject to antitrust approvals and other conditions, with finalization expected by 2025. White & Case marshaled a team led by partners Michael Immordino and Leonardo Graffi to guide these transactions, emphasizing its capacity to manage complex cross-border legal challenges in the pharmaceutical landscape.
Sectors
- Pharmaceuticals
- Legal Services
Geography
- Japan – Takeda, the target company, is based in Japan, anchoring one end of the transactions discussed.
- United Kingdom – Hikma Pharmaceuticals, one of the acquiring companies, is a UK-listed company, indicating the involvement of UK-based companies.
- Spain – Esteve Pharmaceutical, another acquiring company, is based in Spain, highlighting its geographical relevance.
- Middle East and North Africa (MENA) – This region is strategically important as the location where Hikma will market the divested pharmaceutical products.
Industry
- Pharmaceuticals – The article involves transactions in the pharmaceutical industry, focusing on the divestment of pharmaceutical products and oncology assets by Takeda.
- Legal Services – White & Case, a legal advisory firm, is a key participant in the transactions, highlighting the role of professional legal services in M&A activities.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Takeda Pharmaceutical Company Limited | Target Company | Company | A leading global biopharmaceutical company based in Japan. |
| Hikma Pharmaceuticals PLC | Bidding Company | Company | A UK-listed global pharmaceutical company with presence in North America, MENA, and Europe. |
| Esteve Pharmaceutical | Bidding Company | Company | A global pharmaceutical company based in Spain with a strong presence in Europe. |
| White & Case | Legal Advisor | Company | An international law firm advising Takeda in these transactions. |
| Michael Immordino | Legal Advisor | Person | Partner at White & Case leading the advisory team. |
| Leonardo Graffi | Legal Advisor | Person | Partner at White & Case leading the advisory team. |